Intravenous immunoglobulins for Alzheimer’s disease and mild cognitive impairment due to Alzheimer’s disease: A systematic review with meta-analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravenous immunoglobulins for Alzheimer’s disease and mild cognitive impairment due to Alzheimer’s disease: A systematic review with meta-analysis
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume -, Issue -, Pages 1-6
Publisher
Informa UK Limited
Online
2019-05-16
DOI
10.1080/14737175.2019.1620106
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase 3 trial of IV immunoglobulin for Alzheimer disease
- (2017) Norman R. Relkin et al. NEUROLOGY
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia
- (2015) Shawn Kile et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Immune attack: the role of inflammation in Alzheimer disease
- (2015) Frank L. Heppner et al. NATURE REVIEWS NEUROSCIENCE
- Efficacy of Intravenous Immunoglobulin in Neurological Diseases
- (2015) Jan D. Lünemann et al. Neurotherapeutics
- Anti-Aβ Oligomer IgG and Surface Sialic Acid in Intravenous Immunoglobulin: Measurement and Correlation with Clinical Outcomes in Alzheimer’s Disease Treatment
- (2015) Hyewon Kwon et al. PLoS One
- Peroxisome Proliferator-Activated Receptor-Gamma Agonists for Alzheimer’s Disease and Amnestic Mild Cognitive Impairment: A Systematic Review and Meta-Analysis
- (2014) Jia Liu et al. DRUGS & AGING
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and tolerability of immune globulin intravenous (human), 10% solution in Japanese subjects with mild to moderate Alzheimer's disease
- (2014) Heii Arai et al. Psychogeriatrics
- Caregivers of Patients With Dementia in Chinese Mainland
- (2013) Jia Liu et al. American Journal of Alzheimers Disease and Other Dementias
- Mitochondrial Enhancement for Neurodegenerative Movement Disorders: A Systematic Review of Trials Involving Creatine, Coenzyme Q10, Idebenone and Mitoquinone
- (2013) Jia Liu et al. CNS DRUGS
- Intravenous immunoglobulin and Alzheimer’s disease: what now?
- (2013) David A Loeffler Journal of Neuroinflammation
- Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial
- (2013) Richard Dodel et al. LANCET NEUROLOGY
- Dementia in China: Current status
- (2013) J. Liu et al. NEUROLOGY
- The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
- (2009) L. T. Grinberg et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
- (2008) Norman R. Relkin et al. NEUROBIOLOGY OF AGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now